Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s share price traded down 5.4% during trading on Tuesday . The company traded as low as $2.78 and last traded at $2.78. 14,098 shares were traded during mid-day trading, a decline of 98% from the average session volume of 842,200 shares. The stock had previously closed at $2.94.
Ampliphi Biosciences Stock Down 5.8 %
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Featured Articles
- Five stocks we like better than Ampliphi Biosciences
- Best Stocks Under $10.00
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- 5 discounted opportunities for dividend growth investors
- Progress Software Stock Back in the Green After Beating Forecasts
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
